Literature DB >> 1657988

Inhibition of c-erbA mRNA splicing by a naturally occurring antisense RNA.

S H Munroe1, M A Lazar.   

Abstract

The rat erbA alpha locus encodes two overlapping mRNAs, alpha 1 and alpha 2, which are identical except for their most 3' exons. alpha 1 mRNA encodes a thyroid hormone receptor, while alpha 2 encodes an altered ligand binding domain of unknown function. Previous studies have shown that the ratio of alpha 1 to alpha 2 is highest in cells expressing a high level of a third RNA, Rev-ErbA alpha mRNA, which is transcribed in the opposite direction and is complementary to alpha 2 but not alpha 1 mRNA. It was hypothesized that base pairing with Rev-ErbA alpha blocks splicing of alpha 2 mRNA, thereby favoring formation of the non-overlapping alpha 1. To test this model, a system was developed in which alpha 2 pre-mRNAs were accurately spliced in vitro. Splicing was inhibited by the addition of a 5-fold excess of antisense RNAs containing the 3' end of Rev-ErbA alpha mRNA. Both an antisense RNA extending across the 3' splice site and a shorter RNA complementary only to exon sequences efficiently blocked splicing. However, splicing was only inhibited by complementary RNAs. These observations are consistent with a mechanism in which base pairing with a complementary RNA regulates alternative processing of alpha 1 and alpha 2 mRNAs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms.

Authors:  Michal Lapidot; Yitzhak Pilpel
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

Review 2.  Long noncoding RNAs: functional surprises from the RNA world.

Authors:  Jeremy E Wilusz; Hongjae Sunwoo; David L Spector
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

Review 3.  Noncoding RNA in development.

Authors:  Paulo P Amaral; John S Mattick
Journal:  Mamm Genome       Date:  2008-10-07       Impact factor: 2.957

4.  Mapping of small RNAs in the human ENCODE regions.

Authors:  Christelle Borel; Maryline Gagnebin; Corinne Gehrig; Evgenia V Kriventseva; Evgeny M Zdobnov; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2008-04       Impact factor: 11.025

5.  REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American.

Authors:  Marta Garaulet; Caren E Smith; Purificación Gomez-Abellán; María Ordovás-Montañés; Yu-Chi Lee; Laurence D Parnell; Donna K Arnett; José M Ordovás
Journal:  Mol Nutr Food Res       Date:  2013-10-31       Impact factor: 5.914

Review 6.  Antisense and ribozyme constructs in transgenic animals.

Authors:  D L Sokol; J D Murray
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

Review 7.  Non-coding RNAs as regulators of gene expression and epigenetics.

Authors:  Minna U Kaikkonen; Michael T Y Lam; Christopher K Glass
Journal:  Cardiovasc Res       Date:  2011-05-09       Impact factor: 10.787

8.  Single-stranded noncoding RNAs mediate local epigenetic alterations at gene promoters in rat cell lines.

Authors:  Junko Tomikawa; Hiroko Shimokawa; Masahiro Uesaka; Naoki Yamamoto; Yuji Mori; Hiroko Tsukamura; Kei-ichiro Maeda; Takuya Imamura
Journal:  J Biol Chem       Date:  2011-08-15       Impact factor: 5.157

9.  Nuclear receptor profile in calvarial bone cells undergoing osteogenic versus adipogenic differentiation.

Authors:  Flavia Q Pirih; Rosette Abayahoudian; David Elashoff; Farhad Parhami; Jeanne M Nervina; Sotirios Tetradis
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

10.  A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.

Authors:  Manuel Beltran; Isabel Puig; Cristina Peña; José Miguel García; Ana Belén Alvarez; Raúl Peña; Félix Bonilla; Antonio García de Herreros
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.